Sleep Apnea Device Market By Key Manufacturers, By Product (Therapeutics {Airway Clearance System, Adaptive Servo-Ventilation, Positive Airway Pressure (PAP), Oral Appliance, Oxygen Devices}, Diagnostics {Actigraphy System, Polysomnography Device (PSG), Respiratory Polygraph, Single-Channel Screening Devices (Pulse Oximeter)}, By End User (Sleep Laboratories & Hospitals, Home Care/Individuals) and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 41485 | Jan 2019 | No. of Pages: 120 |
The global sleep apnea device market is valued USD 4.2 Billion in 2017 and is projected is to exhibit 7.9% CAGR during the forecast period. The market is projected to be around USD 7.7 Billion by 2026. The market is driven by the rise of lifestyle diseases such as obesity.

Sleep apnea is a disorder in which a patient stops breathing for few seconds at night either because of airway blockage or due to signal from the brain is not received. In unadorned conditions, a person patient of the suffer stops breathing for more than 10 times in an hour. Sleep apnea is also a lifestyle related disease and mostly occurs in geriatric and obese population.
Sleep Apnea Device Market Dynamics
Increasing occurrence of sleep apnea disorder globally paired with increasing geriatric population base is projected to drive the sleep apnea device market during the forthcoming years. Also, lifestyle associated revolution that causes cardiovascular diseases, high stress levels, obesity, unhealthy sleep patterns and postures are expected to boost the growth of the sleep apnea device industry.

Occurrence of sleep apnea is increasing with age and obesity level among persons. Adult populace have consistent habit of snoring that leads to increasing occurrence rate of disruptive sleep apnea. Though, scarcity of patient compliance and costly sleep apnea devices are projected to restrain the growth of the sleep apnea device market.
Sleep Apnea Device Market Insight
North America holds the major market share of the global sleep apnea device market due to presence high occurrence of sleep related diseases, progressive healthcare services, augmented investment in research and development and availability of progressive technology products in the region are driving the demand for sleep apnea device market.
Sleep Apnea Device Market Segmentation
The global sleep apnea device market is segmented into product and region. On the basis of the product the market is further bifurcated into therapeutics device and diagnostics device. The therapeutics device are further segregated into oxygen devices, airway clearance system, positive airway pressure (pap), oral appliance and adaptive servo-ventilation. Also diagnostic devices are further segmented into Single-Channel Screening Devices (Pulse Oximeter}, Actigraphy System, Respiratory Polygraph, and Polysomnography Device (PSG). Based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Sleep Apnea Device Market Competitive Landscape
The players associated with the global sleep apnea device market are Fisher & Paykel Healthcare, Philips, Carefusion, Braebon Medical, Invacare, GE Healthcare, Compumedics, Cadwell Laboratories, and ResMed. These players are focusing on merger & acquisition to extract more business opportunity for instance, In May 2017, Philips announced acquisition of Respiratory Technologies, Inc. The objective of this acquisition is to expand Philip’s sleep and respiratory care business segment.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Sleep Apnea Market, By Product
5.1. Sleep Apnea Market, by Product, 2018-2026
5.2. Therapeutics Device
5.2.1. Airway Clearance System
5.2.2. Adaptive Servo-Ventilation
5.2.3. Positive Airway Pressure (PAP)
5.2.4.Oral Appliance
5.2.5. Oxygen Devices
5.3. Diagnostics Device
5.3.1. Actigraphy System
5.3.2. Polysomnography Device (PSG)
5.3.3. Respiratory Polygraph
5.3.4. Single-Channel Screening Devices (Pulse Oximeter)
Chapter 6. Sleep Apnea Market, By End-user
6.1. Sleep Apnea Market, by End-user, 2018-2026
6.2. Sleep Laboratories & Hospitals
6.3. Home Care/Individuals
Chapter 7. Sleep Apnea Market, By Region
7.1. Sleep Apnea Market, by Region, 2018-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.2. Rest of North America
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC
Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis
Chapter 9. Company Profiles
9.1. Fisher & Paykel Healthcare
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Philips
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Carefusion
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Braebon Medical
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Invacare
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Compumedics
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Cadwell Laboratories
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. ResMed
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. GE Healthcare
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. List of other companies
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
Fisher & Paykel Healthcare
Philips
Carefusion
Braebon Medical
Invacare
GE Healthcare
Compumedics
Cadwell Laboratories
ResMed

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404


Global Bone Substitutes Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 50
$1800
Buy Now
Global Bone Staple Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 51
$1800
Buy Now
Global Bone Punches Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 53
$1800
Buy Now
Global Bone Mineral Testing Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 65
$1800
Buy Now
Global Bone Metabolism Tests Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 51
$1800
Buy Now